Nestle India shares fell on Friday after FSSAI initiated three adjudication cases over alleged violations involving infant nutrition products. The regulator flagged promotional claims on NAN Excella Pro Stage 1 and Lactogen Pro 1 and also found a follow-up formula sample non-conforming for biotin content during laboratory testing.
This story was originally reported by Economic Times — Markets. As an automated real-time news aggregator, NewsToolBar provides multi-perspective indexing and AI summarization while directing full readership directly to primary publisher sources.
Crowd-sourced evaluation based on verified reader feedback
No reader evaluations recorded yet — be the first to rate the coverage tone above!
Quick Story Reactions:
Sign in or create a free reader account to post comments, upvote analysis, and share your perspective.